Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cost-effectiveness
100%
Screening Colonoscopy
100%
Patient Navigation
100%
Quality-adjusted Life Years
83%
Navigation Cost
83%
Life-years Gained
66%
Fecal Immunochemical Test
66%
Colonoscopy
50%
Payers
33%
Fecal Occult Blood Test
33%
Colorectal Cancer Screening
33%
African American
16%
New York City
16%
Hispanic
16%
Reward Outcome
16%
Age 50
16%
Individual Age
16%
Probabilistic Sensitivity Analysis
16%
Participation Rate
16%
Model Validation
16%
Minority Patients
16%
Cost Savings
16%
Population Health
16%
Minority Populations
16%
Screening Participation
16%
Uptake Rate
16%
Healthcare Models
16%
City Population
16%
Testing Uptake
16%
Screening Uptake
16%
Nursing and Health Professions
Patient Care
100%
Cost Effectiveness Analysis
100%
Colonoscopy
100%
Adherence
100%
Quality Adjusted Life Year
55%
Base
22%
Occult Blood
22%
Colorectal Carcinoma
22%
Cancer Screening
22%
Malignant Neoplasm
11%
Urban Population
11%
Cost Control
11%
Health Care
11%
Medicine and Dentistry
Health Care Cost
100%
Patient Care
100%
Cost-Effectiveness Analysis
100%
Colonoscopy
100%
Quality Adjusted Life Year
45%
Base
18%
Colorectal Cancer Screening
18%
Malignant Neoplasm
9%
Health Care
9%
Urban Population
9%
Population Health
9%
Uptake Rates
9%
Biochemistry, Genetics and Molecular Biology
Quality Adjusted Life Year
100%
Fecal Occult Blood
40%
Cancer Screening
40%
Population Health
20%
Urban Population
20%